Please assess the completion status of the following clinical trial:

Trial Title: Japan Statin Treatment Against Recurrent Stroke (J-STARS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ischemic stroke except for cardiogenic embolism, from 1 month to 3 years after onset~* Hyperlipidemia and total cholesterol level of 180-240mg/dl without the prescription of statin within previous 30 days~* Able to visit outpatient department~* Informed consent on the form.~Exclusion Criteria:~* Ischemic stroke of other determined cause according to the TOAST classification~* Ischemic heart disease and necessary to use statin~* Hemorrhagic disorders~* Platelet count \<=100,000/ul within 3 months prior to study start~* Alanine aminotransferase (ALT) or aspartate aminotransferase (AST)\>= 100IU/L within 3 months prior to study start~* Serum creatinine \>=2.0mg/dl within 3 months prior to study start~* A scheduled operation~* The presence of malignant disorder

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Pravastatin (Type: ACTIVE_COMPARATOR): Patient has 10mg oral administration of Pravastatin per day. It starts within one month from their entry and continues every day until the end of the study or its endpoints.
- No intervention (Type: NO_INTERVENTION): Patient has no intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).